Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer
暂无分享，去创建一个
D. Harrison | S. Langdon | I. Um | D. Faratian | C. Kay | A. Sims | M. Muir | A. J. Zweemer | M. Hasmann | S. Langdon | M. Dodds | Y. Nagumo | Charlene Kay | David J. Harrison | Andrew H Sims | Yoko Nagumo | Max Hasmann | Andrew H. Sims